The long-term outlook for children with neuroblastoma greatly depends on the extent (spread) and type (risk-level) of neuroblastoma your child has.
Other factors affecting prognosis include:
the tumor's response to therapy
the age and overall health of your child
your child's tolerance of specific medications, procedures, or therapies
new developments in treatment
the size and location of the tumor
As with any cancer, prognosis and long-term survival can vary greatly from individual to individual. Prompt medical attention and aggressive therapy are important for the best prognosis, and continuous follow-up care is essential for a child diagnosed with neuroblastoma. Side effects of radiation and chemotherapy, as well as recurrence of the disease, can occur in survivors of neuroblastoma.
Children's Hospital Boston is the primary pediatric teaching hospital of Harvard Medical School
